Cargando…

Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients

Complex microbial ecosystems in both gastrointestinal and respiratory systems have been found to have a significant impact on human health. Growing evidence has demonstrated that intestinal dysbiosis can increase vulnerability to pulmonary infections. However, changes in the composition and activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yonglin, Ma, Guannan, Ren, Wei, Hu, Zhenyu, Zhou, Ling, Zhang, Xin, Zhao, Na, Zhang, Mingding, Yan, Lei, Yu, Qian, Liu, Xuetong, Chen, Jichao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695597/
http://dx.doi.org/10.1097/MD.0000000000036320
_version_ 1785153601062043648
author Zhu, Yonglin
Ma, Guannan
Ren, Wei
Hu, Zhenyu
Zhou, Ling
Zhang, Xin
Zhao, Na
Zhang, Mingding
Yan, Lei
Yu, Qian
Liu, Xuetong
Chen, Jichao
author_facet Zhu, Yonglin
Ma, Guannan
Ren, Wei
Hu, Zhenyu
Zhou, Ling
Zhang, Xin
Zhao, Na
Zhang, Mingding
Yan, Lei
Yu, Qian
Liu, Xuetong
Chen, Jichao
author_sort Zhu, Yonglin
collection PubMed
description Complex microbial ecosystems in both gastrointestinal and respiratory systems have been found to have a significant impact on human health. Growing evidence has demonstrated that intestinal dysbiosis can increase vulnerability to pulmonary infections. However, changes in the composition and activity of the intestinal flora after probiotic supplementation may alter the disease state of the host. The effects of probiotics on the improvement of diseases, such as severe pneumonia (SP), in intensive care units (ICUs) remain controversial. We retrospectively included 88 patients diagnosed with severe pneumonia between April 2021 and June 2022. The patients were divided into 2 groups: a probiotic group (n = 40) and a control group (n = 48). In addition, changes in CRP, PCT, WBC, IL-6, Clostridium difficile toxin, and PSI pneumonia scores were assessed. Changes in the gut microbiome of the patients were assessed using amplicon sequencing. Compared to the control group, a significant reduction in the incidence of length of hospital stay was observed in the probiotic group, but there were no significant differences in the mortality rate, duration of fever, diarrhea, and constipation. After probiotic treatment, CRP, PCT, WBC, and PSI score were significantly lower than before, and better clinical efficacy was achieved in the probiotic group for the duration of antibiotic therapy. Gut microbiota analysis revealed that the abundance of opportunistic pathogens (e.g., Massilia) increased remarkably at the genus level in the control group, and a significant increase in Erysipelotrichaceae_ge was observed after probiotic intervention. The control group showed an increase in opportunistic pathogens (Citrobacter, Massilia) during the antibiotic treatment. Probiotics interventions inhibit the growth of opportunistic pathogens. In addition, we found that the population of butyrate-producing bacteria (e.g., Ruminococcaceae UCG-005) increased following probiotic treatment.
format Online
Article
Text
id pubmed-10695597
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106955972023-12-05 Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients Zhu, Yonglin Ma, Guannan Ren, Wei Hu, Zhenyu Zhou, Ling Zhang, Xin Zhao, Na Zhang, Mingding Yan, Lei Yu, Qian Liu, Xuetong Chen, Jichao Medicine (Baltimore) 3900 Complex microbial ecosystems in both gastrointestinal and respiratory systems have been found to have a significant impact on human health. Growing evidence has demonstrated that intestinal dysbiosis can increase vulnerability to pulmonary infections. However, changes in the composition and activity of the intestinal flora after probiotic supplementation may alter the disease state of the host. The effects of probiotics on the improvement of diseases, such as severe pneumonia (SP), in intensive care units (ICUs) remain controversial. We retrospectively included 88 patients diagnosed with severe pneumonia between April 2021 and June 2022. The patients were divided into 2 groups: a probiotic group (n = 40) and a control group (n = 48). In addition, changes in CRP, PCT, WBC, IL-6, Clostridium difficile toxin, and PSI pneumonia scores were assessed. Changes in the gut microbiome of the patients were assessed using amplicon sequencing. Compared to the control group, a significant reduction in the incidence of length of hospital stay was observed in the probiotic group, but there were no significant differences in the mortality rate, duration of fever, diarrhea, and constipation. After probiotic treatment, CRP, PCT, WBC, and PSI score were significantly lower than before, and better clinical efficacy was achieved in the probiotic group for the duration of antibiotic therapy. Gut microbiota analysis revealed that the abundance of opportunistic pathogens (e.g., Massilia) increased remarkably at the genus level in the control group, and a significant increase in Erysipelotrichaceae_ge was observed after probiotic intervention. The control group showed an increase in opportunistic pathogens (Citrobacter, Massilia) during the antibiotic treatment. Probiotics interventions inhibit the growth of opportunistic pathogens. In addition, we found that the population of butyrate-producing bacteria (e.g., Ruminococcaceae UCG-005) increased following probiotic treatment. Lippincott Williams & Wilkins 2023-12-01 /pmc/articles/PMC10695597/ http://dx.doi.org/10.1097/MD.0000000000036320 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3900
Zhu, Yonglin
Ma, Guannan
Ren, Wei
Hu, Zhenyu
Zhou, Ling
Zhang, Xin
Zhao, Na
Zhang, Mingding
Yan, Lei
Yu, Qian
Liu, Xuetong
Chen, Jichao
Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
title Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
title_full Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
title_fullStr Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
title_full_unstemmed Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
title_short Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
title_sort effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients
topic 3900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695597/
http://dx.doi.org/10.1097/MD.0000000000036320
work_keys_str_mv AT zhuyonglin effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT maguannan effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT renwei effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT huzhenyu effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT zhouling effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT zhangxin effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT zhaona effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT zhangmingding effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT yanlei effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT yuqian effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT liuxuetong effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients
AT chenjichao effectoforalprobioticsonclinicalefficacyandintestinalflorainelderlyseverepneumoniapatients